Biobanks Market Demand, Survey, Forecast 2028

According to Premium Market Insights new research study on "biobanks market is projected to reach US$ 3,758.64 million by 2028 from US$ 2,418.31 million in 2021; it is expected to grow at a CAGR of 6.5% during 2021-2028.

Get a Sample Copy of This Report@ https://www.premiummarketinsights.com/sample/TIP00073331/?utm_source=OpenPR&utm_medium=10655

Some Of the Major Players Influencing are THERMO FISHER SCIENTIFIC INC., Tecan Trading AG, QIAGEN, Hamilton Company, Avantor, Inc., MICRONICS JAPAN CO., LTD., BD, Taylor-Wharton, Brooks Automation, Inc, Biovault Family, Promega Corporation, SciSafe Inc.
The market growth is attributed to the growing funding and genomic research activities for studying diseases.

A biobank is a collection of biological samples (such as blood) as well as health data. Biobanks might be vast, including thousands of samples, or small, containing only a few hundred. Different biobanks collect different sorts of samples and information. The information and samples gathered are determined by the biobank's specific function. The term biobank covers collections of plants and animals, including human specimens. Five years ago, genomic sequencing was restricted to the research environment. Genomic sequencing is rapidly transitioning into clinical practice, and implementation into healthcare systems has been supported by substantial government investments, totaling over US$ 4 billion in at least 14 countries. The national genomic-medicine initiatives are driving transformative change under real-life conditions while simultaneously addressing barriers to implementation and gathering evidence for broader adoption, thereby driving the market.
The UK has announced the world's largest genome project as a part of 200 million public-private collaboration between charities and pharma. The country has already developed the largest genome database globally through the 100,000 Genomes Project led by Innovate UK as a part of UK Research and Innovation. The project will fund researchers and industry to combine data and real-world evidence from the UK health services and create new products and services to diagnose diseases earlier and efficiently.

In August 2018, Boston, a Massachusetts-based company, announced that it landed US$ 4.3 million in seed funding, and it would be partnering with Veritas Genetics, a genome sequencing company. The funds will support the company's mission to usher in the era of personal genome sequencing by creating a trusted, secure, and decentralized marketplace for genomic data.

Inquiry Before Buying At: https://www.premiummarketinsights.com/inquiry/TIP00073331/?utm_source=OpenPR&utm_medium=10655

In April 2020, MedGenome-a Bengaluru-based genetic diagnostics, research, and data company-announced that it had raised US$ 55 million (about INR 419 crore) in a new round of funding, led by global impact investment firm LeapFrog Investments. Also, MedGenome claimed that it had built the largest database of South Asian genetic variants in genetic diagnostics in India and research partnerships. It has completed over 200,000 genomic tests to date and obtained samples from more than 550 hospitals and 6,000 clinicians across India.

Biobanks are significant resources in genomic research on infectious diseases and their hosts. The availability of large biobanks is necessary for population genomics. Data from biobanks helps understand the etiology of multifactorial diseases caused by mutations in a range of genes and the influence of environmental variables and lifestyle on the global population. Therefore, the importance of biobanking as a research infrastructure component is expanding. Biobanks have also cleared the path for personalized medicine to evolve, particularly the production of tailored medications. The integration, analysis, and interpretation of data from biobanks play a significant role in understanding genetic susceptibilities to infectious diseases.
Thus, the continuous funding in genomics by the manufacturers and governments and ongoing genomic research activities drive the biobanks market.

Product and Service Insights
Based on product and service, the global biobanks market is segmented into equipment, consumables, services, and software. In 2021, the equipment segment held the largest share of the market. Moreover, the consumables segment is expected to register the highest CAGR in the market during 2021-2028. Equipment plays a vital role in the storage, analysis, processing, and collection of samples in biobanks products also increasing number of products launches in recent years drives the growth of the equipment segment in the forecast period.

Sample Insights
Based on sample, the biobanks market is segmented into blood products, human tissues, cell lines, and others. The blood products segment held the largest market share in 2021. It is further expected to hold a significant market share during the forecast period.

Order a copy of this research study at- https://www.premiummarketinsights.com/buy/TIP00073331/?utm_source=OpenPR&utm_medium=10655

Application Insights
Based on application, the biobanks market is segmented into regenerative medicine, life science research, and clinical research. The regenerative medicine segment held the largest market share in 2021. The life science research segment is expected to hold a significant market share during the forecast period.
A few major primary and secondary sources referred to while preparing the report on the global biobanks market are the World Health Organization, Pharmaceutical Research and Manufacturers of America (PhRMA), Global Cancer Observatory, European Federation of Pharmaceutical Industries and Associations (EFPIA), National Institute for Health Research (NHS), and American Heart Association.

Table Of Contents
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Biobanks Market - By Product and Service
1.3.2 Global Biobanks Market - By Sample
1.3.3 Global Biobanks Market - By Application
1.3.4 Global Biobanks Market - By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Biobanks Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East And Africa PEST Analysis
4.2.5 South And Central America PEST Analysis
4.3 Experts Opinion
5. Biobanks Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Funding and Genomic Research Activities for Studying Diseases
5.1.2 Increasing Pharmaceutical and Biopharmaceutical R&D Expenditures
5.1.3 Rising Adoption of Regenerative Medicines
5.2 Market Restraints
5.2.1 High Cost of Automation
5.3 Market Opportunities
5.3.1 Increasing Adoption of Cell Therapy in Developing Regions
5.4 Future Trends
5.4.1 Virtual Biobanks
5.5 Impact Analysis
Continued…...!

Contact Us:
If you have any queries pertaining to the report or would like further information, feel free to reach out to us at-
Contact Person: Sameer Joshi
E-mail: sales@premiummarketinsights.com
Phone: +1-646-491-9876

About Us:
Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost-effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.
Premium Market Insights has an extensive coverage of industry reports, company reports and country reports across all industries. In case your research needs are not met by syndicated reports offered by leading publishers, we can help you by offering a customized research solution by liaising with different research agencies saving your valuable time and money.
We provide best in class customer service and our customer support team is always available to help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider. We also offer enterprise subscriptions which provide significant cost savings to our clients.

This release was published on openPR.